Prevalence of Influenza RelAted Invasive Aspergillosis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Influenza, Human
- Invasive Pulmonary Aspergillosis
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This is a multicenter prospective observational study conducted at 12 intensive care units (ICU) in Sweden. All patients >18 years of age with a Polymerase Chain Reaction (PCR)-verified influenza A or B diagnosed up to 7 days before admission to the ICU or during ICU care, will be included in the st...
This is a multicenter prospective observational study conducted at 12 intensive care units (ICU) in Sweden. All patients >18 years of age with a Polymerase Chain Reaction (PCR)-verified influenza A or B diagnosed up to 7 days before admission to the ICU or during ICU care, will be included in the study. A new clinical routine has been implemented at the study centers: During the ICU stay screening with Beta-D-glucan and Galactomannan in blood/serum will be performed twice weekly and a respiratory sample will be retrieved for fungal culture and microscopy once weekly. All results from collected samples will be available to the patient's attending physicians. Clinical and microbiological data will be collected, and the diagnosis of invasive aspergillosis will be made using predefined diagnostic criteria. Objectives: To determine the prevalence of influenza-related invasive pulmonary aspergillosis in Swedish intensive care units To assess the clinical impact of and risk factors for influenza-related invasive pulmonary aspergillosis
Tracking Information
- NCT #
- NCT04172610
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Anders Krifors, M.D. Karolinska Institutet Study Director: Markus Castegren, M.D. Ph.D. Karolinska Institutet Study Chair: Ola Blennow, M.D. Ph.D. Karolinska Institutet Study Chair: Johan Petersson, M.D. A/Prof. Karolinska Institutet